Skip to main content

Toll Brothers to Acquire Private Home Builder in Northwest Arkansas

FORT WASHINGTON, Pa., April 21, 2026 (GLOBE NEWSWIRE) — Toll Brothers, Inc. (NYSE:TOL), the nation’s leading builder of luxury homes, today announced that it has signed a definitive agreement to acquire substantially all the assets of Buffington Homes of Arkansas, a privately held home builder based in Fayetteville, Arkansas. The transaction is expected to close in the Company’s fiscal third quarter. The acquisition will augment Toll Brothers’ national footprint by establishing a strong presence in the dynamic Fayetteville/Bentonville housing market in northwest Arkansas. Founded in 2010, Buffington Homes is the largest luxury home builder in northwest Arkansas with nine active selling/coming soon communities in the region. The company serves primarily first-time and move-up home buyers with prices ranging from the $400,000s to...

Continue reading

Weatherford Announces First Quarter 2026 Results

First quarter revenue of $1,152 million decreased 3% year-over-year First quarter operating income of $123 million decreased 13% year-over-year First quarter net income of $108 million increased 42% year-over-year; net income margin of 9.4% First quarter adjusted EBITDA* of $233 million, decreased 8% year-over-year; adjusted EBITDA margin* of 20.2% decreased 98 basis points year-over-year First quarter cash provided by operating activities of $136 million and adjusted free cash flow* of $85 million Shareholder return of $30 million for the quarter, which included dividend payments of $20 million and share repurchases of $10 million Awarded a multi-year Integrated Completions contract to support offshore operations in Denmark by TotalEnergies Awarded a five-year contract to provide TRS for offshore operations in Vietnam by Phu Quoc POC Announced...

Continue reading

GCC Reports First Quarter 2026 Results

CHIHUAHUA, Mexico, April 21, 2026 (GLOBE NEWSWIRE) — GCC, S.A.B. de C.V. (BMV: GCC*), a leading supplier and producer of cement, aggregates, and concrete in the United States and Mexico, announced today its results for the first quarter of 2026. Q1 2026 HIGHLIGHTSConsolidated net sales increased 19.8% year-on-year to US$295.4 million U.S. sales grew 15.9% as concrete and cement volumes increased 15.9% and 10.6%, respectively U.S. concrete prices increased 27.8% Mexico sales grew 28.2% as cement and concrete volumes increased 12.8% and 5.9%, respectively Mexico concrete prices increased 1.2% EBITDA increased 18.3% to US$87.1 million, with a 29.5% EBITDA margin Cash and equivalents totaled US$857.3 million Net leverage (net debt/EBITDA) ratio totaled -0.47x as of March 2026 Earnings per share increased 19% year-on-year, to US$0.1475 GCC...

Continue reading

STERIS to Host a Conference Call for Fiscal 2026 Fourth Quarter and Full Year Results on May 12, 2026

DUBLIN, IRELAND, April 21, 2026 (GLOBE NEWSWIRE) — STERIS plc (NYSE: STE) (“STERIS” or the “Company”) announced today that it will host a conference call to discuss its fiscal 2026 fourth quarter and full year results at 9:00 a.m. ET on May 12, 2026. The conference call can be heard live at www.steris-ir.com or via phone by dialing 1-833-535-2199 in the United States or 1-412-902-6776 internationally, then asking to join the conference call for STERIS plc. A press release detailing financial results will be issued after the U.S. market closes on May 11, 2026. For those unable to listen to the conference call live, a replay will be available beginning at 12:00 p.m. ET on May 12, 2026, either at www.steris-ir.com or via phone. To access the replay of the call, please use the access code 3141167 and dial 1-855-669-9658 in the United...

Continue reading

Veeco Announces Date for First Quarter 2026 Financial Results and Conference Call

PLAINVIEW, N.Y., April 21, 2026 (GLOBE NEWSWIRE) — Veeco Instruments Inc. (NASDAQ: VECO) plans to release its first quarter 2026 financial results after the market closes on Tuesday, May 5, 2026. The company will host a conference call to review these results starting at 5:00 PM ET that day. To join the call, dial 1-877-407-8029 (toll-free) or 1-201-689-8029. Participants may also access a live webcast of the call by visiting Veeco’s investor relations website at ir.veeco.com. A replay of the webcast will be made available on the Veeco website beginning at 8:00 PM ET that same evening. About Veeco Veeco (NASDAQ: VECO) is an innovative manufacturer of semiconductor process equipment. Our laser annealing, ion beam, metal organic chemical vapor deposition (MOCVD), single wafer etch & clean and lithography technologies play...

Continue reading

BJ’s Restaurants, Inc. Announces Date for First Quarter 2026 Earnings Release and Conference Call

HUNTINGTON BEACH, Cali., April 21, 2026 (GLOBE NEWSWIRE) — BJ’s Restaurants, Inc. (NASDAQ: BJRI) today announced that it will release its first quarter 2026 results after the market closes on Tuesday, May 5, 2026. The Company will host an investor conference call at 2:00 p.m. (Pacific) that same day. The conference call will be broadcast live over the Internet. To listen to the conference call, please visit the “Investors” page of the Company’s website located at http://www.bjsrestaurants.com several minutes prior to the start of the call to register and download any necessary audio software. An archive of the presentation will be available for 30 days following the call. About BJ’s Restaurants, Inc. BJ’s Restaurants, Inc. is a national casual dining brand with brewhouse roots. Founded in 1978, BJ’s owns and operates over...

Continue reading

HCI Group Sets 2026 Annual Shareholders Meeting and Record Date

TAMPA, Fla., April 21, 2026 (GLOBE NEWSWIRE) — HCI Group, Inc. (NYSE: HCI) will hold its Annual Meeting of Shareholders on Wednesday, June 10, 2026, at 3:00 p.m. Eastern Time in the 1st Floor Auditorium of HCI’s headquarters at 3802 Coconut Palm Drive, Tampa, Florida. Shareholders of record at the close of business on Monday, April 13, 2026, will be entitled to vote and attend the meeting. Items of business will include the following proposals:To elect one Class B Director and three Class C Directors To ratify the appointment of external auditors To approve, on an advisory basis, the compensation of the named executive officersShareholders will also consider such other business as may properly come before the Annual Meeting and any adjournments or postponements thereof. About HCI Group, Inc. HCI Group, Inc. is a diversified...

Continue reading

Fennec Pharmaceuticals Announces Acceptance of Abstracts at the 2026 ASCO Annual Meeting

– Data from Four Studies Spotlight Rising Clinical Interest & Urgency to Address Cisplatin-Induced Hearing Loss and Its Lasting Impact on Patients – RESEARCH TRIANGLE PARK, N.C., April 21, 2026 (GLOBE NEWSWIRE) — Fennec Pharmaceuticals Inc. (NASDAQ:FENC; TSX: FRX), a specialty pharmaceutical company, today announced that four abstracts evaluating PEDMARK® (sodium thiosulfate injection) were accepted as part of the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting program, taking place May 29-June 2, 2026 in Chicago, IL. PEDMARK® is currently approved for pediatric patients one month of age and older with localized, non-metastatic solid tumors, and is also recognized by the National Comprehensive Cancer Network with a 2A recommendation for use in adolescent and young adult patients. Poster Presentation Details: Title:...

Continue reading

Aspen Aerogels Provides East Providence Facility Update

NORTHBOROUGH, Mass., April 21, 2026 (GLOBE NEWSWIRE) — Aspen Aerogels, Inc. (NYSE: ASPN) (“Aspen” or the “Company”) today provided an update on its manufacturing facility in East Providence, Rhode Island. As previously reported, an explosion occurred at Aspen’s manufacturing facility in East Providence, Rhode Island on the evening of April 8, 2026. The explosion damaged a portion of the facility’s production space and required the temporary cessation of operations. The investigation into the cause of the incident is ongoing. Preliminary reports indicate the explosion originated in a specific high-temperature oven. Eleven employees at the facility were transported to local medical facilities for evaluation and were subsequently released. As of April 21, 2026, the facility remains offline. The Company continues to work...

Continue reading

Rapport Therapeutics Presents RAP-219 Focal Onset Seizure Phase 2a Follow-up Period Results Demonstrating Sustained Seizure Reduction at the 2026 American Academy of Neurology Annual Meeting

Clinically meaningful efficacy demonstrated in the 8-week follow-up period (weeks 9-16), with a 90% median reduction in clinical seizures over baseline in weeks 9-12 and a 59% median reduction in clinical seizures over baseline in weeks 13-16 New data demonstrate that RAP-219 has a half-life of approximately 22 days RAP-219 was generally well tolerated throughout treatment and follow-up periods BOSTON and SAN DIEGO, April 21, 2026 (GLOBE NEWSWIRE) — Rapport Therapeutics, Inc. (Nasdaq: RAPP) (“Rapport” or the “Company”), a clinical-stage biotechnology company dedicated to the discovery and development of small molecule precision medicines for patients with neurological or psychiatric disorders, today announced results from the follow-up period of its Phase 2a trial of RAP-219 in focal onset seizures (FOS) in a late-breaker podium...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.